CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease
- 21 December 2004
- journal article
- guideline
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (25) , e545-9
- https://doi.org/10.1161/01.cir.0000148980.87579.5e
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Standardization of Immunoassays for Measurement of High-Sensitivity C-reactive Protein. Phase I: Evaluation of Secondary Reference MaterialsClinical Chemistry, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Natalizumab for Active Crohn's DiseaseNew England Journal of Medicine, 2003
- EFFECTS OF SAMPLE HANDLING ON THE STABILITY OF INTERLEUKIN 6, TUMOUR NECROSIS FACTOR-α AND LEPTINCytokine, 2000
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Evaluation of an Automated Method for Cytokine Measurement Using the Immulite® Immunoassay Systemcclm, 1999
- Measurement of plasma fibrinogen concentration by the prothrombin-time-derived methodBlood Coagulation & Fibrinolysis, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standardsJournal of Immunological Methods, 1995
- Inaccuracy of the ‘derived’ fibrinogen measurementBlood Coagulation & Fibrinolysis, 1994